The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hussell, T.
Right arrow Articles by Openshaw, P. J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hussell, T.
Right arrow Articles by Openshaw, P. J. M.
The Journal of Immunology, 2000, 165: 7109-7115.
Copyright © 2000 by The American Association of Immunologists

IL-12-Activated NK Cells Reduce Lung Eosinophilia to the Attachment Protein of Respiratory Syncytial Virus But Do Not Enhance the Severity of Illness in CD8 T Cell-Immunodeficient Conditions1

Tracy Hussell2 and Peter J. M. Openshaw

Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine Medical School, Norfolk Place, London, United Kingdom

Bronchiolitis caused by respiratory syncytial virus (RSV) infection is a major cause of hospitalization in children under 1 year of age. RSV causes common colds in older children and adults, but can cause serious disease in immunodeficient patients and the elderly. Development of effective vaccines and treatments for RSV infection is therefore a priority. Because bronchiolitis and vaccine-augmented disease are thought to be caused by exuberant T cell activation, attention has focused on the use of immunomodulators that affect T cell responses. In mice, IL-12 treatment down-regulates type 2 cytokine responses to the attachment protein G of RSV, reducing lung eosinophilia but further enhancing illness. We now show that CD8+ T cells are responsible for enhanced weight loss, whereas IL-12-activated NK cells express high levels of IFN-{gamma} and inhibit lung eosinophilia without causing illness. Moreover, unlike immunocompetent mice, virus is detected in the mediastinal lymph nodes after elimination of both CD8+ T cells and NK cells. These studies show that innate immune responses to viral infections direct the pattern of subsequent specific immunity and are critical to the development of nonpathogenic antiviral effects. We speculate that IL-12 treatment might be beneficial and safe in T cell-deficient patients with RSV pneumonitis.




This article has been cited by other articles:


Home page
J. Virol.Home page
P. K. Pribul, J. Harker, B. Wang, H. Wang, J. S. Tregoning, J. Schwarze, and P. J. M. Openshaw
Alveolar Macrophages Are a Major Determinant of Early Responses to Viral Lung Infection but Do Not Influence Subsequent Disease Development
J. Virol., May 1, 2008; 82(9): 4441 - 4448.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Miller, C. Gerard, M. Schaller, A. D. Gruber, A. A. Humbles, and N. W. Lukacs
Deletion of CCR1 Attenuates Pathophysiologic Responses during Respiratory Syncytial Virus Infection
J. Immunol., February 15, 2006; 176(4): 2562 - 2567.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. D. Rudd, J. J. Smit, R. A. Flavell, L. Alexopoulou, M. A. Schaller, A. Gruber, A. A. Berlin, and N. W. Lukacs
Deletion of TLR3 Alters the Pulmonary Immune Environment and Mucus Production during Respiratory Syncytial Virus Infection
J. Immunol., February 1, 2006; 176(3): 1937 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
P. J. M. Openshaw and J. S. Tregoning
Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection
Clin. Microbiol. Rev., July 1, 2005; 18(3): 541 - 555.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. M.L. van Herpen, J. A.W.M. van der Laak, I. J. M. de Vries, J. H. van Krieken, P. C. de Wilde, M. G.J. Balvers, G. J. Adema, and P. H.M. De Mulder
Intratumoral Recombinant Human Interleukin-12 Administration in Head and Neck Squamous Cell Carcinoma Patients Modifies Locoregional Lymph Node Architecture and Induces Natural Killer Cell Infiltration in the Primary Tumor
Clin. Cancer Res., March 1, 2005; 11(5): 1899 - 1909.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-Z. Wang, Y.-X. Bao, C. L. Rosenberger, Y. Tesfaigzi, J. M. Stark, and K. S. Harrod
IL-12p40 and IL-18 Modulate Inflammatory and Immune Responses to Respiratory Syncytial Virus Infection
J. Immunol., September 15, 2004; 173(6): 4040 - 4049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. B. Mailliard, Y.-I. Son, R. Redlinger, P. T. Coates, A. Giermasz, P. A. Morel, W. J. Storkus, and P. Kalinski
Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function
J. Immunol., September 1, 2003; 171(5): 2366 - 2373.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
F. J. Culley, J. Pollott, and P. J.M. Openshaw
Age at First Viral Infection Determines the Pattern of T Cell-mediated Disease during Reinfection in Adulthood
J. Exp. Med., November 18, 2002; 196(10): 1381 - 1386.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.